Improvement in the Health of HIV-Infected Persons in Care: Reducing Disparities
Open Access
- 26 September 2012
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 55 (9) , 1242-1251
Abstract
Background. Despite advances in human immunodeficiency virus (HIV) treatment, major challenges remain in achieving access, retention, and adherence. Our inner-city HIV clinical practice in Baltimore has a diverse patient population with high rates of poverty, black race, and injection drug use (IDU), providing us the opportunity to compare health process and outcomes. Methods. Using data collected in a clinical HIV cohort in Baltimore, we compared receipt of combination antiretroviral therapy (ART), HIV type 1 (HIV-1) RNA, CD4, incidence of opportunistic illness, and mortality from 1995 to 2010. Comparisons were made of these outcomes by HIV risk group, sex, and race (black, white). Results. From 1995 to 2010, we followed 6366 patients comprising 27 941 person-years (PY) of follow-up. By 2010, 87% of patients were receiving ART; median HIV-1 RNA was 3, opportunistic illness rates were 2.4 per 100 PY, and mortality rates were 2.1 per 100 PY, with no differences by demographic or HIV risk group. The only differences were that the IDU risk group had a median CD4 that was 79 cells/mm3 lower and HIV-1 RNA 0.16 log10 copies/mL higher compared with other risk groups (P < .01). In 2009 a 28-year-old HIV-infected person was estimated to have 45.4 years of life remaining, which did not differ by demographic or behavioral risk group. Discussion. Our results emphasize that advances in HIV treatment have had a positive impact on all affected demographic and behavioral risk groups in an HIV clinical setting, with an expected longevity for HIV-infected patients that is now 73 years.Keywords
This publication has 34 references indexed in Scilit:
- Essential Components of Effective HIV Care: A Policy Paper of the HIV Medicine Association of the Infectious Diseases Society of America and the Ryan White Medical Providers CoalitionClinical Infectious Diseases, 2011
- Dramatic Decline in the HIV-1 RNA Level Over Calendar Time in a Large Urban HIV PracticeClinical Infectious Diseases, 2011
- HIV Treatment Outcomes Among HIV-Infected, Opioid-Dependent Patients Receiving Buprenorphine/Naloxone Treatment within HIV Clinical Care Settings: Results From a Multisite StudyJAIDS Journal of Acquired Immune Deficiency Syndromes, 2011
- Contemporary costs of HIV healthcare in the HAART eraAIDS, 2010
- Increased Black–White Disparities in Mortality After the Introduction of Lifesaving Innovations: A Possible Consequence of US Federal LawsAmerican Journal of Public Health, 2010
- AIDS-defining opportunistic illnesses in US patients, 1994–2007: a cohort studyAIDS, 2010
- Examination of Inequalities in HIV/AIDS Mortality in the United States From a Fundamental Cause PerspectiveAmerican Journal of Public Health, 2010
- Impact of Drug Abuse Treatment Modalities on Adherence to ART/HAART Among a Cohort of HIV Seropositive WomenThe American Journal of Drug and Alcohol Abuse, 2008
- Adherence, virological and immunological outcomes for HIV-infected veterans starting combination antiretroviral therapiesAIDS, 2007
- Effect of Race and/or Ethnicity in Use of Antiretrovirals and Prophylaxis for Opportunistic Infection: A Review of the LiteraturePublic Health Reports®, 2002